ACADIAN ASSET MANAGEMENT LLC

Position in PMVP — PMV Pharmaceuticals, Inc.

CIK 916542 Boston, MA

Position in PMVP

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$2,747,708

+$227,996 QoQ

Shares Held

2,215,894

+9.9% QoQ

Ownership

4.15%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $658,704,928 across 179 Biotechnology names. PMVP ranks #39 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,900,824	$178,905,554
2	REGN	Regeneron Pharmaceuticals, Inc.	151,191	$116,816,214
3	LEGN	Legend Biotech Corp	1,527,336	$27,629,508
4	TBPH	Theravance Biopharma, Inc.	1,276,576	$20,718,828
5	RIGL	Rigel Pharmaceuticals Inc	666,426	$18,020,159
6	IMCR	Immunocore Holdings plc	501,091	$15,107,893
7	PRTA	Prothena Corp Public Ltd Co	1,547,593	$15,042,603
8	PBYI	Puma Biotechnology, Inc.	2,041,759	$13,046,840

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,747,708	2,215,894	+9.9%	Shares	Defined	2026-05-13
2025-12-31	$2,519,712	2,015,770	-2.4%	Shares	Defined	2026-02-10
2025-09-30	$2,892,591	2,066,137	0.0%	Shares	Defined	2025-11-13
2025-06-30	$2,190,105	2,066,137	+0.9%	Shares	Defined	2025-08-07
2025-03-31	$2,231,422	2,047,177	-1.5%	Shares	Defined	2025-05-21
2024-12-31	$3,139,087	2,078,866	0.0%	Shares	Defined	2025-02-11
2024-09-30	$3,097,510	2,078,866	0.0%	Shares	Defined	2024-11-12
2024-06-30	$3,367,762	2,078,866	-0.1%	Shares	Defined	2024-08-06
2024-03-31	$3,536,329	2,080,194	+170.7%	Shares	Defined	2024-05-10
2023-12-31	$2,382,191	768,449	—	Shares	Defined	2024-02-13
No filing history on record for this holder in this stock.